Bart de Keizer

47PUBLICATIONS
177CO-AUTHORS
Medical mycologyPredictive and prognostic markersRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (47)

|Aug 24, 2026
Omitting Bone Marrow Sampling in FDG-Avid Rhabdomyosarcoma With 2-[18F]FDG PET-Negative Marrow: Results From an International Retrospective Study.

|Mar 27, 2026
FDG-PET medullary total tumor volume highlights high-risk patients with newly diagnosed multiple myeloma in CASSIOPEIA trial.

Bastien Jamet, Shamimeh Ahrari, Sonja Zweegman

|Mar 13, 2026
Imaging of High-Risk Neuroblastoma: Recommendations From SIOPEN Radiology and Nuclear Medicine Specialty Committees.

Annemieke Littooij, Catia Olianti, Herve Brisse

|Mar 04, 2026
Pituitary dysfunction in childhood after [177Lu]Lu-DOTATATE therapy.

Karen van Wessel, Bart de Keizer, Miranda P Dierselhuis

|Jan 27, 2026
Limited Sensitivity of Ultrasound-Guided Fine-Needle Aspiration Cytology for Occult Nodal Metastases in Early-Stage Oral Squamous Cell Carcinoma.

Dominique N V Donders, Roosmarijn S Tellman, Sammy M Schouten

|Sep 24, 2025
Prognostic value of premaintenance FDG PET/CT response in patients with newly diagnosed myeloma from the CASSIOPEIA trial.

Françoise Kraeber-Bodéré, Bastien Jamet, Sonja Zweegman

Pageof 8

Frequent Collaborators

15 joint publications

Remco de Bree

8 joint publications

Rutger Mahieu

8 joint publications

Arthur J A T Braat

7 joint publications

Rob van Rooij